Skip to Main Content
BLACK FRIDAY SALE

60% off Quiver Premium for new subscribers

...

Use Promo Code:

BLACKFRIDAY26
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

BrightSpring Health Services Slides as Recent Rally Cools Without a Clear New Catalyst

None

BrightSpring Health Services (BTSG) is down 6.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is a pullback after a strong post-earnings run rather than a fresh company-specific negative announcement. This could be because the shares had recently climbed toward their highs, and there does not appear to be a new operating update, earnings warning, or major filing tied directly to today’s decline.

Details:

  • The company last reported third-quarter 2026 results in late October and raised its full-year 2026 revenue and adjusted EBITDA outlook, which had helped drive a sharp move higher earlier this month.
  • Management also told investors at a healthcare conference in November that growth trends were still on track, suggesting no obvious deterioration in the underlying business had been publicly flagged.
  • A recent ownership filing was posted in mid-November, but it was a beneficial ownership update rather than a new earnings or guidance event, so it does not clearly explain a one-day drop of this size.
  • Analyst coverage visible this week remained constructive, including a higher price target, which points more toward profit-taking, valuation pressure, or broader healthcare-services weakness as a likely driver.
  • Sources:

    BrightSpring Health Services Investor Relations, U.S. Securities and Exchange Commission, Benzinga, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $BTSG Insider Trading Activity

    BTSG Insider Trades

    $BTSG insiders have traded $BTSG stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

    Here’s a breakdown of recent trading of $BTSG stock by insiders over the last 6 months:

    • GROUP PARTNERSHIP L.P. KKR sold 14,669,771 shares for an estimated $857,492,124
    • PHOENIX AGGREGATOR L.P. KKR sold 14,669,771 shares for an estimated $857,492,124
    • JON B ROUSSEAU (See Remarks) has made 0 purchases and 2 sales selling 260,000 shares for an estimated $15,275,000.
    • LISA A NALLEY (See Remarks) sold 35,000 shares for an estimated $2,056,250
    • JENNIFER A PHIPPS (Chief Financial Officer) sold 35,000 shares for an estimated $2,056,250
    • SCOTT A. GREENWELL (President, PharMerica) sold 15,099 shares for an estimated $874,383

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive BTSG Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $BTSG Hedge Fund Activity

    We have seen 298 institutional investors add shares of $BTSG stock to their portfolio, and 224 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $BTSG Analyst Ratings

    Wall Street analysts have issued reports on $BTSG in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • BMO Capital issued a "Outperform" rating on 11/18/2026
    • Guggenheim issued a "Buy" rating on 11/03/2026
    • UBS issued a "Buy" rating on 11/02/2026
    • Leerink Partners issued a "Outperform" rating on 11/02/2026
    • TD Cowen issued a "Buy" rating on 11/02/2026
    • Wells Fargo issued a "Overweight" rating on 11/02/2026
    • BTIG issued a "Buy" rating on 08/13/2026

    To track analyst ratings and price targets for $BTSG, check out Quiver Quantitative's $BTSG forecast page.

    $BTSG Price Targets

    Multiple analysts have issued price targets for $BTSG recently. We have seen 12 analysts offer price targets for $BTSG in the last 6 months, with a median target of $83.0.

    Here are some recent targets:

    • Sean Dodge from BMO Capital set a target price of $84.0 on 11/18/2026
    • Jason Cassorla from Guggenheim set a target price of $84.0 on 11/03/2026
    • A.J. Rice from UBS set a target price of $92.0 on 11/02/2026
    • Whit Mayo from Leerink Partners set a target price of $92.0 on 11/02/2026
    • Charles Rhyee from TD Cowen set a target price of $84.0 on 11/02/2026
    • Stephen Baxter from Wells Fargo set a target price of $82.0 on 11/02/2026
    • David Larsen from BTIG set a target price of $90.0 on 08/13/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles